Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium Article uri icon

Overview

MeSH Major

  • Genes, Neoplasm
  • Myeloproliferative Disorders

abstract

  • Immediately after the annual scientific meeting of the American Society of Hematology (ASH), a select group of clinical and laboratory investigators in myeloproliferative neoplasms (MPN) is summoned to a post-ASH conference on chronic myeloid leukemia and the BCR-ABL1-negative MPN. The 6th such meeting occurred on December 13–14,2011, in La Jolla, California, USA, under the direction of its founder,Dr. Tariq Mughal. The current document is the first of two reports on this post-ASH event and summarizes the most recent preclinical and clinical advances in polycythemia vera, essential thrombocythemia,and primary myelofibrosis.

publication date

  • May 2012

Research

keywords

  • Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3491640

Digital Object Identifier (DOI)

  • 10.1002/ajh.23169

PubMed ID

  • 22460584

Additional Document Info

start page

  • 562

end page

  • 8

volume

  • 87

number

  • 5